Houston, TX, United States of America

Kiran Kumar Pulukuri

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: William Marsh Rice University. Active years: 2022.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kiran Kumar Pulukuri

Introduction

Kiran Kumar Pulukuri is an accomplished inventor based in Houston, Texas. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. With a total of two patents to his name, his work focuses on innovative compounds that have the potential to improve cancer treatment.

Latest Patents

Kiran Kumar Pulukuri's latest patents include the synthesis of disorazoles and analogs thereof as potent anticancer agents. This patent provides disorazole analogs of a specific formula, along with methods for preparing these compounds. It also includes pharmaceutical compositions and methods of use, as well as drug conjugates with cell-targeting moieties. Another notable patent is for tubulysin analogues as anticancer agents and payloads for antibody-drug conjugates. Similar to his previous work, this patent outlines the formula for tubulysin analogs, methods of preparation, and pharmaceutical applications.

Career Highlights

Kiran Kumar Pulukuri is affiliated with William Marsh Rice University, where he conducts research and develops innovative solutions in the field of cancer therapeutics. His work has garnered attention for its potential impact on cancer treatment methodologies.

Collaborations

Kiran has collaborated with esteemed colleagues such as Kyriacos Costa Nicolaou and Stephan Rigol, contributing to a rich environment of innovation and research.

Conclusion

Kiran Kumar Pulukuri's contributions to the field of medicinal chemistry through his patents and research at William Marsh Rice University highlight his commitment to advancing cancer treatment. His innovative work continues to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…